Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Lunai Bioworks Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −3 vs. Q2 2021
- Shares held
- 1.52M
- −1.15M (−43.1%) vs. Q2 2021
- Total value
- $10.2M
- −$3.04M (−22.9%) vs. Q2 2021
- New holders
- 7
- 8 more added
- Sold out
- 10
- 13 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LNAI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $641.0K |
| Q1 2026 | 29 | $403.3K |
| Q4 2025 | 24 | $981.7K |
| Q3 2025 | 20 | $1.38M |
| Q2 2025 | 45 | $4.17M |
| Q1 2025 | 63 | $12.0M |
| Q4 2024 | 58 | $18.5M |
| Q3 2024 | 50 | $7.13M |
| Q2 2024 | 39 | $24.8M |
| Q1 2024 | 41 | $19.2M |
| Q4 2023 | 36 | $8.16M |
| Q3 2023 | 21 | $6.65M |
| Q2 2023 | 32 | $1.13M |
| Q1 2023 | 40 | $3.02M |
| Q4 2022 | 39 | $3.74M |
| Q3 2022 | 43 | $6.87M |
| Q2 2022 | 51 | $7.64M |
| Q1 2022 | 43 | $21.5M |
| Q4 2021 | 44 | $18.0M |
| Q3 2021 | 34 | $10.2M |
| Q2 2021 | 37 | $13.3M |
| Q1 2021 | 41 | $9.60M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Lunai Bioworks Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 257,056 | $1.73M | 0.00% | −16,600−6.1% | Reduced |
| Invesco Ltd. | 254,071 | $1.71M | 0.00% | +254,071 | New |
| Geode Capital Management, LLC | 207,568 | $1.40M | 0.00% | +59,509+40.2% | Added |
| Morgan Stanley | 136,729 | $920.0K | 0.00% | +117,742+620.1% | Added |
| BlackRock Inc. | 95,144 | $640.0K | 0.00% | −47,278−33.2% | Reduced |
| Dimensional Fund Advisors LP | 80,675 | $543.0K | 0.00% | −150−0.2% | Reduced |
| Sabby Management, LLC | 79,314 | $534.0K | 0.12% | −1,262,349−94.1% | Reduced |
| Truist Financial Corp | 78,444 | $528.0K | 0.00% | +18,784+31.5% | Added |
| United Capital Financial Advisers, LLC | 71,291 | $480.0K | 0.00% | +23,600+49.5% | Added |
| State Street Corp | 48,291 | $325.0K | 0.00% | +15,500+47.3% | Added |
| Cubist Systematic Strategies, LLC | 31,314 | $211.0K | 0.00% | +31,314 | New |
| Northern Trust Corp | 28,103 | $189.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 25,257 | $170.0K | 0.00% | −17,211−40.5% | Reduced |
| First Trust Advisors LP | 21,420 | $144.0K | 0.00% | −16,198−43.1% | Reduced |
| Citadel Advisors LLC | 19,509 | $132.0K | 0.00% | +19,509 | New |
| ETF Managers Group, LLC | 18,848 | $126.0K | 0.00% | +4,749+33.7% | Added |
| Parametric Portfolio Associates LLC | 18,494 | $124.0K | 0.00% | −3,293−15.1% | Reduced |
| Blair William & Co | 17,000 | $114.0K | 0.00% | +17,000 | New |
| Bank of New York Mellon Corp | 10,529 | $71.0K | 0.00% | −848−7.5% | Reduced |
| Dorsey Wright & Associates | 7,869 | $53.0K | 0.01% | +7,869 | New |
| Jacobi Capital Management LLC | 6,650 | $45.0K | 0.01% | +2,150+47.8% | Added |
| Skandinaviska Enskilda Banken AB (publ) | 2,250 | $15.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,362 | $9.00K | 0.00% | +1,362 | New |
| Citigroup Inc | 804 | $5.00K | 0.00% | +751+1,417.0% | Added |
| Meeder Asset Management Inc | 574 | $3.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 80 | $1.00K | 0.00% | −4,321−98.2% | Reduced |
| Wells Fargo & Company | 92 | $1.00K | 0.00% | −3−3.2% | Reduced |
| O'Shaughnessy Asset Management, LLC | 119 | $1.00K | 0.00% | +119 | New |
| BNP Paribas Arbitrage, SA | 144 | $969 | 0.00% | −3,141−95.6% | Reduced |
| TD Private Client Wealth LLC | 125 | $841 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 10 | $0 | 0.00% | −199−95.2% | Reduced |
| UBS Group AG | 15 | $0 | 0.00% | −245−94.2% | Reduced |
| Cutler Group LP | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Ellis Investment Partners, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −116,666−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −68,007−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −47,984−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −41,900−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −41,058−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −18,127−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,948−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −3,908−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −2,702−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −96−100.0% | Sold out |